PetVivo Holdings, Inc. – NASDAQ:PETV
PetVivo Holdings stock price today
PetVivo Holdings stock price monthly change
PetVivo Holdings stock price quarterly change
PetVivo Holdings stock price yearly change
PetVivo Holdings key metrics
Market Cap | 9.78M |
Enterprise value | 28.15M |
P/E | -3.37 |
EV/Sales | 33.24 |
EV/EBITDA | -3.57 |
Price/Sales | 33.38 |
Price/Book | 36.05 |
PEG ratio | 0.08 |
EPS | -0.77 |
Revenue | 280.32K |
EBITDA | -7.99M |
Income | -8.39M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -964.01% |
Oper. margin | -965.91% |
Gross margin | 38.38% |
EBIT margin | -965.91% |
EBITDA margin | -2850.81% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePetVivo Holdings stock price history
PetVivo Holdings stock forecast
PetVivo Holdings financial statements
| Dec 2021 | 51.00K | -1.64M | -3219.61% |
|---|---|---|---|
| Mar 2022 | 55.46K | -1.77M | -3203.25% |
| Mar 2023 | 125.59K | -2.32M | -1854.29% |
| Mar 2024 | 48.26K | -2.65M | -5491.89% |
| 2026 | 8.9M | -9.8M | -110.11% |
|---|
Analysts Price target
Financials & Ratios estimates
| Sep 2022 | 4050809 | 1.48M | 36.72% |
|---|---|---|---|
| Dec 2022 | 2568295 | 1.78M | 69.47% |
| Mar 2023 | 2438952 | 1.71M | 70.27% |
| Mar 2024 | 3115253 | 2.42M | 77.98% |
| Dec 2021 | -1.46M | -74.84K | 276.45K |
|---|---|---|---|
| Mar 2022 | -1.36M | -72.12K | -5.31K |
| Mar 2023 | -1.29M | -130.08K | 1.52M |
| Mar 2024 | -1.52M | -29.30K | 1.56M |
PetVivo Holdings alternative data
| Aug 2023 | 25 |
|---|---|
| Sep 2023 | 25 |
| Oct 2023 | 25 |
| Nov 2023 | 25 |
| Dec 2023 | 25 |
| Jan 2024 | 25 |
| Feb 2024 | 25 |
| Mar 2024 | 25 |
| Apr 2024 | 25 |
| May 2024 | 25 |
| Jun 2024 | 25 |
| Jul 2024 | 25 |
PetVivo Holdings other data
| Period | Buy | Sel |
|---|---|---|
| Aug 2023 | 22224 | 0 |
| Apr 2024 | 150000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | LAI JOHN director, officer.. | Common Stock | 150,000 | $0.6 | $90,000 | ||
Purchase | MARTIN JAMES RUDOLPH director | Common Stock | 7,300 | $2.35 | $17,155 | ||
Purchase | MARTIN JAMES RUDOLPH director | Common Stock | 4,482 | $2.21 | $9,905 | ||
Purchase | MARTIN JAMES RUDOLPH director | Common Stock | 300 | $2.18 | $654 | ||
Purchase | MARTIN JAMES RUDOLPH director | Common Stock | 218 | $2.2 | $480 | ||
Purchase | MARTIN JAMES RUDOLPH director | Common Stock | 1,850 | $2.29 | $4,237 | ||
Purchase | MARTIN JAMES RUDOLPH director | Common Stock | 200 | $2.32 | $464 | ||
Purchase | MARTIN JAMES RUDOLPH director | Common Stock | 24 | $2.15 | $52 | ||
Purchase | MARTIN JAMES RUDOLPH director | Common Stock | 2,600 | $2.33 | $6,058 | ||
Purchase | MARTIN JAMES RUDOLPH director | Common Stock | 850 | $2.27 | $1,930 |
| Quarter | Transcript |
|---|---|
| Q3 2024 12 Feb 2024 | Q3 2024 Earnings Call Transcript |
| Q2 2024 14 Nov 2023 | Q2 2024 Earnings Call Transcript |
| Q1 2024 11 Aug 2023 | Q1 2024 Earnings Call Transcript |
| Q3 2023 9 Feb 2023 | Q3 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. John Lai (1962) Chief Executive Officer, Pres & Director | $91,670 |
| Dr. David B. Masters Ph.D. (1958) Director of Science & Technology and Director | $71,500 |
Mr. John F. Dolan (1965) Gen. Counsel, Chief Bus. Devel. Officer, Sec. & Executive Director | $40,250 |
| Mr. Randall A. Meyer (1964) Chief Operating Officer & Director | $15,830 |
-
What's the price of PetVivo Holdings stock today?
One share of PetVivo Holdings stock can currently be purchased for approximately $0.87.
-
When is PetVivo Holdings's next earnings date?
Unfortunately, PetVivo Holdings's (PETV) next earnings date is currently unknown.
-
Does PetVivo Holdings pay dividends?
No, PetVivo Holdings does not pay dividends.
-
How much money does PetVivo Holdings make?
PetVivo Holdings has a market capitalization of 9.78M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 5.62% to 968.71K US dollars.
-
What is PetVivo Holdings's stock symbol?
PetVivo Holdings, Inc. is traded on the NASDAQ under the ticker symbol "PETV".
-
What is PetVivo Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of PetVivo Holdings?
Shares of PetVivo Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are PetVivo Holdings's key executives?
PetVivo Holdings's management team includes the following people:
- Mr. John Lai Chief Executive Officer, Pres & Director(age: 63, pay: $91,670)
- Dr. David B. Masters Ph.D. Director of Science & Technology and Director(age: 67, pay: $71,500)
- Mr. John F. Dolan Gen. Counsel, Chief Bus. Devel. Officer, Sec. & Executive Director(age: 60, pay: $40,250)
- Mr. Randall A. Meyer Chief Operating Officer & Director(age: 61, pay: $15,830)
-
How many employees does PetVivo Holdings have?
As Jul 2024, PetVivo Holdings employs 25 workers.
-
When PetVivo Holdings went public?
PetVivo Holdings, Inc. is publicly traded company for more then 11 years since IPO on 8 Sep 2014.
-
What is PetVivo Holdings's official website?
The official website for PetVivo Holdings is petvivo.com.
-
Where are PetVivo Holdings's headquarters?
PetVivo Holdings is headquartered at 5251 Edina Industrial Boulevard, Minneapolis, MN.
-
How can i contact PetVivo Holdings?
PetVivo Holdings's mailing address is 5251 Edina Industrial Boulevard, Minneapolis, MN and company can be reached via phone at +95 2 405 6216.
PetVivo Holdings company profile:
PetVivo Holdings, Inc.
petvivo.comNASDAQ
20
Medical - Devices
Healthcare
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
Minneapolis, MN 55439
CIK: 0001512922
ISIN: US7168174081
CUSIP: 716817408
